Tessera
Folgen

Máté Kiss

@matekiss.bsky.social

Group Leader at the Georg-Speyer-Haus Institute in Frankfurt, Germany

8 Posts91 Follower129 Folgt
Frankfurt Cancer Institute@loewe-fci.bsky.social · 7mo ago

⏰ Reminder: Abstracts for the Frankfurt Cancer Conference 2026 are due Mar 26! Share your research and connect with leading cancer researchers. 📅 September 2–4, 2026 📍 @Goethe University Frankfurt (Campus Westend) 🔗 www.frankfurtcancerconference.org #FrankfurtCancerConference

Cancer Conference 2026 - UCT Frankfurt

The Frankfurt Cancer Conference is a meeting of internationally leading cancer researchers in basic and translational as well as clinical research. It's also an ideal forum for early-career scientists...

frankfurtcancerconference.org

Alaz Ozcan@alazozcan.bsky.social · 7mo ago

Thrilled to welcome the wonderful @adrover.bsky.social to Zurich for our monthly SMyLe @smyle-ch.bsky.social seminar! 📅 March 24 | 16:30 📍 ETH Hönggerberg Join us to hear José present his great science! Special thanks to @syis-ecr.bsky.social for supporting this event!

Swiss Myeloid League (SMyLe)@smyle-ch.bsky.social · 7mo ago

The next SMyLe seminar is coming up soon! Please join us on March 24th at 16.30 at ETH Höngg (HCI J6) or via Zoom (ethz.zoom.us/j/63706799264) for a talk by @adrover.bsky.social "From Guardians to Foes: Cancer-induced host remodelling and neutrophil plasticity drive tumour necrosis and metastasis"

Laoui Team @ VIB-VUB@laouimmunology.bsky.social · 8mo ago

One week left to register for the FEBS Advanced Course on Tumour Microenvironment: From Tumour Heterogeneity to Therapy Resistance. which will be held in May 4-8, 2026, in Crete! 🧑‍🔬 🧪 🔬 There is an excellent line up of internationally recognized speakers! tumourmicroenvironment2026.febsevents.org

FEBS Advanced Lecture Course 2026 - Tumour microenvironment: From tumour heterogeneity to therapy resistance

4–8 May 2026 │ Fodele, Greece

tumourmicroenvironment2026.febsevents.org

Máté Kiss@matekiss.bsky.social · 8mo ago

Our institute is organizing a conference in September with a fantastic list of speakers. Please share with anyone who may be interested!

Frankfurt Cancer Institute@loewe-fci.bsky.social · 8mo ago

📣 Registration and Abstract Submission Open: FRANKFURT CANCER CONFERENCE 2026 Translating Paul Ehrlich’s Magic Bullet into Novel Targeted Therapies 🕗 September 2–4, 2026 📍Campus Westend, @goetheuni.bsky.social, Frankfurt/Main, DE ➡️ frankfurtcancerconference.org #FrankfurtCancerConference

Alaz Ozcan@alazozcan.bsky.social · 9mo ago

Really excited for the first SMyLe Seminar Series event of 2026! Looking forward to the opening seminar on Feb 17 at 16:30 with Dr. Máté Kiss. Hope to see many myeloid enthusiasts there and to keep the discussions going over the apero 🍷

Swiss Myeloid League (SMyLe)@smyle-ch.bsky.social · 9mo ago

Happy to announce our very first SMyLe seminar. Please join us for this exciting talk entitled "Transcriptional regulation of neutrophil plasticity in cancer" by Dr. Máté Kiss @matekiss.bsky.social on February 17th at 16.30 at ETH Höngg (HCI J6) or via Zoom (ethz.zoom.us/j/63706799264).

Beatrice Zitti@beatricezitti.bsky.social · 10mo ago

‼️ New study alert ‼️ We are really proud to share that our latest research is finally out 📣 In this work, we explore the spatial and functional regulation of dendritic cells (DCs) within the tumor microenvironment and how these mechanisms impact #cancerprogression and response to #immunotherapy 🧵

Immunity@cp-immunity.bsky.social · 10mo ago

Online now: Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity

CalcinottoLab@calcinottolab.bsky.social · last yr.

🚀 Excited to share our latest publication! 👉 www.nature.com/articles/s41... A fantastic collaboration with an incredible team. #BreastCancer #Neutrophils #TumorMicroenvironment #PARPinhibitors #DNARepair #NatureCommunications #CancerImmunology #CalcinottoLab

Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition - Nature Communications

Tumor-associated neutrophils exhibit heterogeneity in breast cancer. Here, the authors identify a distinct precursor population (PreNeu) in estrogen receptor-positive tumors. PreNeu suppress homologou...

nature.com

Máté Kiss@matekiss.bsky.social · last yr.

Our new paper is out: Tumors don’t just reprogram monocytes locally. We show in a mouse model that the systemic impact of a tumor can alter the epigenome of peripheral monocytes, repressing IFN-responsive regulatory elements and priming pro-tumor gene programs.

Epigenomic preconditioning of peripheral monocytes determines their transcriptional response to the tumor microenvironment - Genome Medicine

Background Monocytes are recruited to tumors and undergo transcriptional reprogramming resulting in tumor-promoting functions. Epigenomic features, such as post-translational modification of histones ...

genomemedicine.biomedcentral.com

Máté Kiss@matekiss.bsky.social · last yr.

Happy to share that I’ll be starting my lab as a junior group leader at the Georg-Speyer-Haus in Frankfurt in 2026. We’ll study how transcriptional regulators control neutrophil function in cancer. I’ll be hiring soon (PhD/lab tech), please reach out if you know someone interested!